首页>
外国专利>
USE OF A PLASMA HOMOCYSTEINE CONTENT REDUCING AGENT FOR THE REDUCTION OF THE THROMBOEMBOLIC SIDE EFFECT RISK INDUCED BY GESTAGEN TYPE HORMONES
USE OF A PLASMA HOMOCYSTEINE CONTENT REDUCING AGENT FOR THE REDUCTION OF THE THROMBOEMBOLIC SIDE EFFECT RISK INDUCED BY GESTAGEN TYPE HORMONES
展开▼
机译:血浆同型半胱氨酸含量降低剂在降低由生殖激素型激素引起的血栓双侧副作用中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to pharmaceutical composition(s) comprising gestogen type steroid hormone(s) and compound(s) lowering in human plasma the level of homocysteine, capable of lowering the risk of thromboembolic side effects of gestogen type compositions. The plasma homocysteine content reducing agents may be selected from folic acid, vitamin B6, vitamin B12, betaine, choline, acetyl cysteine and metabolic precursors, analogues and/or derivatives thereof. The invention is also directed to the use of said plasma reducing agents.
展开▼